Worsening of obsessive-compulsive symptoms after treatment with aripiprazole.
Mouaffak
Fayçal
F
Gallarda
Thierry
T
Baylé
Franck Jean
FJ
Olié
Jean Pierre
JP
Baup
Nicolas
N
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use; D000068180:Aripiprazole; D005260:Female; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000139:chemically induced* / Q000188:drug therapy*; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use*; D015363:Quinolones / Q000009:adverse effects* / Q000627:therapeutic use*; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole